RFP Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-190
Closed -$204K 77
2025
Q4
$204K Sell
190
-842
-82% -$805K 0.1% 75
2025
Q3
$795K Buy
1,032
+101
+11% +$75.2K 0.32% 46
2025
Q2
$726K Hold
931
0.3% 47
2025
Q1
$769K Sell
931
-265
-22% -$221K 0.31% 54
2024
Q4
$923K Sell
1,196
-1,384
-54% -$1.15M 0.36% 45
2024
Q3
$2.28M Buy
2,580
+1,218
+89% +$1.1M 0.74% 25
2024
Q2
$1.23M Buy
1,362
+13
+1% +$10.4K 0.46% 38
2024
Q1
$1.05M Buy
1,349
+32
+2% +$22.8K 0.41% 41
2023
Q4
$767K Buy
1,317
+42
+3% +$24.5K 0.31% 46
2023
Q3
$684K Sell
1,275
-46
-3% -$23.7K 0.3% 47
2023
Q2
$620K Buy
1,321
+258
+24% +$108K 0.25% 53
2023
Q1
$365K Sell
1,063
-269
-20% -$90.7K 0.42% 27
2022
Q4
$487K Buy
+1,332
New +$472K 0.22% 56

Other funds holding LLY

RFP Financial Group's LLY Position: Q1 2026 in Review

RFP Financial Group sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 190 shares — an estimated $204K sold.

RFP Financial Group first reported a position in LLY in Q4 2022 and held it in 13 quarters. The position peaked at $2.28M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • RFP Financial Group reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • RFP Financial Group sold 190 Eli Lilly shares in Q1 2026, an estimated $204K.
  • RFP Financial Group first reported a position in Eli Lilly in Q4 2022 and held it in 13 quarters.
  • RFP Financial Group's Eli Lilly position peaked at $2.28M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on RFP Financial Group's 13F filing for Q1 2026, filed 13 May 2026.